The Food and Drugs Authority (FDA) on Wednesday debunked the assertion that the COVID-19 Testing regime used for passengers at the Kotoka International Airport (KIA) is unreliable.
A statement issued and signed by Mrs Delasse A. Darko, the Chief Executive Officer of FDA, and copied to the Ghana News Agency in Accra on Wednesday, said the device at KIA "detects the ANTIGEN (SARS-CoV-2 Virus) by fluorescence technology," adding that it was, therefore, not a Rapid Diagnostic Test Kit.
The FDA statement seeks to clarify claims by Dr Kofi Bonney of the Noguchi Memorial Institute for Medical Research that the device being used for testing at the Airport was unreliable.
The statement said the FDA gave market authorisation to the device after a specificity and sensitivity comparison with the PCR tests.
It said the device met the requirements of not less than 99.0 per cent concordance.
“The FDA wishes to assure the public that the device approved for use at the KIA is fit for purpose and the Authority shall continue to monitor its performance in accordance with regulatory requirements,” it said.
- Eleven African countries report presence of 501Y.V2 variant: Africa CDC
- Over 200 coronavirus deaths in 30 days as Ghana’s fatalities reach 640
- China February exports post record surge from coronavirus-depressed 2020 levels
- Christaina Awuni details how she was nearly sacked from a coronavirus vaccination centre
- ‘Ghana CARES Obaatanpa' programme to lead path towards economic recovery – Akufo-Addo
- Read all related articles
